Calumet Specialty Prods: Q1 Earnings Insights

Calumet Specialty Prods (NASDAQ:CLMT) reported its Q1 earnings results on Friday, May 5, 2023 at 07:00 AM. Here’s…

Calumet Specialty Prods (NASDAQ:CLMT) reported its Q1 earnings results on Friday, May 5, 2023 at 07:00 AM.

Here’s what investors need to know about the announcement.

Earnings

Calumet Specialty Prods beat estimated earnings by 400.0%, reporting an EPS of $0.35 versus an estimate of $0.07.

Revenue was down $61.00 million from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.86 which was followed by a 8.12% increase in the share price the next day.

Here’s a look at Calumet Specialty Prods’s past performance:

Quarter Q4 2022 Q3 2022 Q2 2022 Q1 2022
EPS Estimate 0 0.33 0.27 -0.52
EPS Actual -0.86 0.19 -0.19 -1.18
Revenue Estimate 904.43M 1.01B 1.18B 841.30M
Revenue Actual 999.80M 1.17B 1.42B 1.10B

To track all earnings releases for Calumet Specialty Prods visit their earnings calendar here.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

Total
0
Shares
Related Posts
Read More

CBD of Denver Reports YoY Increase In 2023 Gross Profit, Reduces Loss As It Continues To Expand Internationally

CBD of Denver, Inc. has filed its financial results for the year ended Dec. 31, 2023.The Colorado-based cannabis company said total current assets increased to $117,218 in 2023, up from $28,043 in 2022. Gross profit for the year totaled $595,417, representing a significant recovery from a gross loss of $284,734 in the prior year, due to a 27% increase in sales and a reduction in cost of goods sold. Net income before provision for income tax showed improvement with a loss of $377,729 in 2023, compared to a loss of $3,257,710 in 2022. CBD of Denver attributed it to the company's efforts to enhance operational efficiency and improve cost management.

CBDD